81 related articles for article (PubMed ID: 23123160)
1. Meprins process matrix metalloproteinase-9 (MMP-9)/gelatinase B and enhance the activation kinetics by MMP-3.
Geurts N; Becker-Pauly C; Martens E; Proost P; Van den Steen PE; Stöcker W; Opdenakker G
FEBS Lett; 2012 Dec; 586(24):4264-9. PubMed ID: 23123160
[TBL] [Abstract][Full Text] [Related]
2. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): the next decade.
Vandooren J; Van den Steen PE; Opdenakker G
Crit Rev Biochem Mol Biol; 2013; 48(3):222-72. PubMed ID: 23547785
[TBL] [Abstract][Full Text] [Related]
3. Beta-hematin interaction with the hemopexin domain of gelatinase B/MMP-9 provokes autocatalytic processing of the propeptide, thereby priming activation by MMP-3.
Geurts N; Martens E; Van Aelst I; Proost P; Opdenakker G; Van den Steen PE
Biochemistry; 2008 Feb; 47(8):2689-99. PubMed ID: 18237197
[TBL] [Abstract][Full Text] [Related]
4. Pro-MMP-9 is a specific macrophage product and is activated by osteoarthritic chondrocytes via MMP-3 or a MT1-MMP/MMP-13 cascade.
Dreier R; Grässel S; Fuchs S; Schaumburger J; Bruckner P
Exp Cell Res; 2004 Jul; 297(2):303-12. PubMed ID: 15212936
[TBL] [Abstract][Full Text] [Related]
5. Significance of coexpression of urokinase-type plasminogen activator, and matrix metalloproteinase 3 (stromelysin) and 9 (gelatinase B) in colorectal carcinoma.
Inuzuka K; Ogata Y; Nagase H; Shirouzu K
J Surg Res; 2000 Oct; 93(2):211-8. PubMed ID: 11027463
[TBL] [Abstract][Full Text] [Related]
6. Propeptide glycosylation and galectin-3 binding decrease proteolytic activation of human proMMP-9/progelatinase B.
Boon L; Ugarte-Berzal E; Martens E; Vandooren J; Rybakin V; Colau D; Gordon-Alonso M; van der Bruggen P; Stöcker W; Becker-Pauly C; Witters P; Morava E; Jaeken J; Proost P; Opdenakker G
FEBS J; 2019 Mar; 286(5):930-945. PubMed ID: 30422384
[TBL] [Abstract][Full Text] [Related]
7. Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2).
Fridman R; Toth M; Peña D; Mobashery S
Cancer Res; 1995 Jun; 55(12):2548-55. PubMed ID: 7780967
[TBL] [Abstract][Full Text] [Related]
8. Direct activation of pro-matrix metalloproteinase-2 by leukolysin/membrane-type 6 matrix metalloproteinase/matrix metalloproteinase 25 at the asn(109)-Tyr bond.
Nie J; Pei D
Cancer Res; 2003 Oct; 63(20):6758-62. PubMed ID: 14583471
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the protease activity that cleaves the extracellular domain of beta-dystroglycan.
Zhong D; Saito F; Saito Y; Nakamura A; Shimizu T; Matsumura K
Biochem Biophys Res Commun; 2006 Jun; 345(2):867-71. PubMed ID: 16701552
[TBL] [Abstract][Full Text] [Related]
10. Natural haemozoin modulates matrix metalloproteinases and induces morphological changes in human microvascular endothelium.
Prato M; D'Alessandro S; Van den Steen PE; Opdenakker G; Arese P; Taramelli D; Basilico N
Cell Microbiol; 2011 Aug; 13(8):1275-85. PubMed ID: 21707906
[TBL] [Abstract][Full Text] [Related]
11. Meprin proteolytic complexes at the cell surface and in extracellular spaces.
Villa JP; Bertenshaw GP; Bylander JE; Bond JS
Biochem Soc Symp; 2003; (70):53-63. PubMed ID: 14587282
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of membrane-type 1-matrix metalloproteinase (MT1-MMP) production and sequential activation of progelatinase A on human squamous carcinoma cells co-cultured with human dermal fibroblasts.
Sato T; Iwai M; Sakai T; Sato H; Seiki M; Mori Y; Ito A
Br J Cancer; 1999 Jun; 80(8):1137-43. PubMed ID: 10376963
[TBL] [Abstract][Full Text] [Related]
13. Regulation of human monocyte proMMP-9 production by fetuin, an endogenous TGF-beta antagonist.
Tajirian T; Dennis JW; Swallow CJ
J Cell Physiol; 2000 Nov; 185(2):174-83. PubMed ID: 11025439
[TBL] [Abstract][Full Text] [Related]
14. Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP).
Worley JR; Thompkins PB; Lee MH; Hutton M; Soloway P; Edwards DR; Murphy G; Knäuper V
Biochem J; 2003 Jun; 372(Pt 3):799-809. PubMed ID: 12630911
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of proteases involved in embryo implantation by cholesterol sulfate.
Koizumi M; Momoeda M; Hiroi H; Nakazawa F; Nakae H; Ohno T; Yano T; Taketani Y
Hum Reprod; 2010 Jan; 25(1):192-7. PubMed ID: 19897854
[TBL] [Abstract][Full Text] [Related]
16. Differential induction of gelatinase B (MMP-9) and gelatinase A (MMP-2) in T lymphocytes upon alpha(4)beta(1)-mediated adhesion to VCAM-1 and the CS-1 peptide of fibronectin.
Yakubenko VP; Lobb RR; Plow EF; Ugarova TP
Exp Cell Res; 2000 Oct; 260(1):73-84. PubMed ID: 11010812
[TBL] [Abstract][Full Text] [Related]
17. Activation mechanisms of the precursors of matrix metalloproteinases 1, 2 and 3.
Nagase H; Suzuki K; Morodomi T; Enghild JJ; Salvesen G
Matrix Suppl; 1992; 1():237-44. PubMed ID: 1480033
[TBL] [Abstract][Full Text] [Related]
18. Regulation of collagenase, stromelysin, and gelatinase B in human conjunctival and conjunctivochalasis fibroblasts by interleukin-1beta and tumor necrosis factor-alpha.
Meller D; Li DQ; Tseng SC
Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):2922-9. PubMed ID: 10967046
[TBL] [Abstract][Full Text] [Related]
19. Independent regulation of matrix metalloproteinases and plasminogen activators in human fibrosarcoma cells.
Lim YT; Sugiura Y; Laug WE; Sun B; Garcia A; DeClerck YA
J Cell Physiol; 1996 May; 167(2):333-40. PubMed ID: 8613475
[TBL] [Abstract][Full Text] [Related]
20. Regulation of human monocyte matrix metalloproteinases by SPARC.
Shankavaram UT; DeWitt DL; Funk SE; Sage EH; Wahl LM
J Cell Physiol; 1997 Dec; 173(3):327-34. PubMed ID: 9369945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
